Prof. Steven Chamuleau, MD, PhD

Is a cardiologist and head of department of Cardiology at the Amsterdam University Medical Centers (Amsterdam UMC, the Netherlands), specialized in cardiac regenerative therapy, valvular disease and cardiac imaging. He combines state-of-the-art cardiac care with promising experimental techniques and tries to implement new strategies and techniques in the pre-clinical as well as the clinical phase. As both a clinician and PI, Steven is well known for his translational work and vision.

He finished medical school in Amsterdam and subsequently received his PhD degree cum laude in 2001 on intracoronary derived physiological parameters for clinical decision making at the Academic Medical Center (AMC) in Amsterdam under supervision of Prof. Jan Piek and Prof. Jan Tijssen. After his PhD he started his residency at the AMC Amsterdam, where he also did his fellowship training in cardiology and cardiac imaging. After a year in Louisville, KY, USA in the lab of the renowned Prof. Bolli, focusing on cardiac stem cell treatment, he received a position as a staff cardiologist at the UMC Utrecht (2008-2019) were he became deputy head of the department, and supervisor for the specialisation Cardiology.

Prof. Chamuleau has published over 160 peer-reviewed papers and is an active member in the Dutch and European Society of Cardiology, and scientific advisory board of the Dutch Heart Foundation, and the International Society of Cardiovascular Translational Research (ISCTR). He is a reviewer for many cardiac journals, such as EHJ and Circulation. At the moment he is a (co-)PI in several large international research consortia and clinical trials, primarily focused on stem cell treatmet, and valvular disease. He manages a large group of PhD Students, and became Professor of Cardiology at UMC Utrecht in 2016, and since 2020 in Amsterdam UMC.

Steven Chamuleau

Prof. Pieter Doevendans MD PhD FESCĀ 

Is Chief of the Department of Cardiology and professor in Experimental Cardiology at the UMC Utrecht. Pieter A. Doevendans serves or has served as board member for several international and national scientific committees or editorial boards. As principal investigator for several prestigious European and Dutch grants, coordinates and executes several research projects that investigate the potency of cardiomyocyte progenitor cells as a novel clinical application in cardiac repair. Pieter A. Doevendans is currently co director of the Netherlands Heart Institute.

Pieter Doevendans